Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification. [PDF]
Tseng TC, Huang SC, Kao JH.
europepmc +1 more source
Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma. [PDF]
Yang ZH, Liu SN, Chu FY, Yang C, Chen X.
europepmc +1 more source
The Role of Vitamin K Deficiency in Chronic Kidney Disease-A Scoping Review. [PDF]
Tybjerg Wegge V +3 more
europepmc +1 more source
Development and validation of a high-confidence diagnostic model integrating ctDNA methylation and serum biomarkers for early-stage hepatocellular carcinoma detection. [PDF]
Wu H +16 more
europepmc +1 more source
GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation. [PDF]
Qiao W +5 more
europepmc +1 more source
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therapy: a case report. [PDF]
Zhou Y, Guo B, Zhou H, Wang N, Xiao Z.
europepmc +1 more source
A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE). [PDF]
Asaoka Y +19 more
europepmc +1 more source
Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model. [PDF]
Xiong Y +5 more
europepmc +1 more source
A Case of Vitamin K Deficiency Bleeding in a Newborn: Catastrophic Yet Preventable. [PDF]
Nmadu YW +5 more
europepmc +1 more source
Comment on "Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab". [PDF]
Li B +6 more
europepmc +1 more source

